APOBEC in breast cancer: a dual player in tumor evolution and therapeutic response
The APOBEC (Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like) family of cytidine deaminases has emerged as pivotal a contributor to genomic instability and adaptive immunity through DNA/RNA editing. Accumulating evidence underscores their dual role in breast carcinogenesis—driving tu...
Saved in:
| Main Authors: | Haiqi Lu, Zelin Lu, Yufei Wang, Miaoqin Chen, Guangliang Li, Xian Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Molecular Biosciences |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2025.1604313/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progression
by: Zexi He, et al.
Published: (2025-08-01) -
APOBEC3 Proteins: From Antiviral Immunity to Oncogenic Drivers in HPV-Positive Cancers
by: Eliza Pizarro Castilha, et al.
Published: (2025-03-01) -
Design and Characterization of Inhibitors of Cell-Mediated Degradation of APOBEC3G That Decrease HIV-1 Infectivity
by: Aubrey M. Sawyer, et al.
Published: (2025-04-01) -
Viral infection, APOBEC3 dysregulation, and cancer
by: Jake Lehle, et al.
Published: (2024-12-01) -
DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B
by: Yanmeng Chen, et al.
Published: (2020-01-01)